India to Senegal: Sulfadoxine Export Trade Route

The India to Senegal Sulfadoxine corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $3.5M USD. The route is dominated by S KANT HEALTHCARE LIMITED, which alone accounts for roughly 89% of all export value, reflecting the consolidated nature of India's sulfadoxine manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $313.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with sulfadoxine's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 27.7%, placing it at rank #20 among India's top sulfadoxine export destinations globally.

On the import side, key buyers of Indian sulfadoxine in Senegal include TO THE ORDER., TO THE ORDER, TO THE DIRECTOR and 1 others. TO THE ORDER. is the single largest importer with 2 shipments valued at $1.7M USD.

India's sulfadoxine exports to Senegal are driven primarily by a handful of large-scale manufacturers. S KANT HEALTHCARE LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Senegal benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — S KANT HEALTHCARE LIMITED, SCOTT EDIL PHARMACIA LIMITED, FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $313.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine amodiaquine 150mg +sulfadoxine/pyrimethamine 500/25mg dispersible tablets (supyra dispersible) unit :5nos and amodiaquine 75mg+sulfadoxine/pyrimethamine 250/12.5 mg dispersible tablet (supyra dispersible junior) unit :50(1+3)co-blnos, suggesting that buyers in Senegal tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER. is the largest importer with 2 shipments worth $1.7M USD — representing 49% of all sulfadoxine imports from India on this route.